Corporate News 12-Aug-21
Board of Natco Pharma recommends Interim Dividend
Of Rs.2 per share
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2021, has recommended a Interim dividend of Rs.2 per share (i.e.100%), subject to the approval of the shareholders.
Previous News
Natco Pharma's Vizag unit completes USFDA inspection
( Corporate News - 04-Feb-23 11:07 )
Natco Pharma fixes record date for 3rd interim dividend
( Market Beat - Reports 14-Feb-22 19:07 )
Natco Pharma Ltd up for third straight session
( Hot Pursuit - 25-Jan-24 13:06 )
Natco Pharma temporarily shuts operations at Chennai-based plant
( Hot Pursuit - 07-Dec-23 15:14 )
Natco Pharma gets USFDA nod for colorectal cancer drug
( Hot Pursuit - 16-Jun-23 10:22 )
Natco Pharma to table results
( Corporate News - 01-Feb-23 16:51 )
Board of Natco Pharma recommends Third Interim Dividend
( Corporate News - 10-Feb-23 10:10 )
Natco Pharma launches first generic version of Pomalyst® capsules
( Corporate News - 09-Nov-22 12:21 )
Board of Natco Pharma approves appointment of Chairman
( Corporate News - 14-Feb-22 19:09 )
Board of Natco Pharma recommends Second Interim Dividend
( Corporate News - 11-Nov-22 10:43 )
Volumes soar at Natco Pharma Ltd counter
( Hot Pursuit - 22-May-20 11:00 )
Other Stories
Board of NRB Bearings recommends interim dividend
05-Oct-24 09:27
Refex Industries to hold EGM
05-Oct-24 09:26
Allcargo Terminals to hold EGM
05-Oct-24 09:26
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Back
Top
